Institutional investors hold a majority ownership of AGN through the 92.56% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended September 2014, these large investors purchased a net $3.5 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 2.9 Million shares of Allergan
T. ROWE PRICE ASSOCIATES, INC. Bought 2.3 Million shares of Allergan
WADDELL & REED INVESTMENT MANAGE... Bought 1.8 Million shares of Allergan